Your browser doesn't support javascript.
loading
Enhancers of mesenchymal stem cell stemness and therapeutic potency.
Al-Azab, Mahmoud; Idiiatullina, Elina; Safi, Mohammed; Hezam, Kamal.
Afiliación
  • Al-Azab M; Department of Immunology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou 510623, China. Electronic address: azab.m12@gmail.com.
  • Idiiatullina E; Department of Immunology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou 510623, China; Department of Therapy and Nursing, Bashkir State Medical University, Ufa 450008, Russia.
  • Safi M; Department of Respiratory Diseases, Shandong Second Provincial General Hospital, Shandong University, Shandong, China.
  • Hezam K; Nankai University School of Medicine, Tianjin 300071, China; Department of Microbiology, Faculty of Applied Science, Taiz University, 6350 Taiz, Yemen.
Biomed Pharmacother ; 162: 114356, 2023 Jun.
Article en En | MEDLINE | ID: mdl-37040673
ABSTRACT
Mesenchymal stem cells (MSCs) are multipotent stromal cells that can differentiate into a range of cell types, including osteoblasts, chondrocytes, myocytes, and adipocytes. Multiple preclinical investigations and clinical trials employed enhanced MSCs-dependent therapies in treatment of inflammatory and degenerative diseases. They have demonstrated considerable and prospective therapeutic potentials even though the large-scale use remains a problem. Several strategies have been used to improve the therapeutic potency of MSCs in cellular therapy. Treatment of MSCs utilizing pharmaceutical compounds, cytokines, growth factors, hormones, and vitamins have shown potential outcomes in boosting MSCs' stemness. In this study, we reviewed the current advances in enhancing techniques that attempt to promote MSCs' therapeutic effectiveness in cellular therapy and stemness in vivo with potential mechanisms and applications.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trasplante de Células Madre Mesenquimatosas / Células Madre Mesenquimatosas Idioma: En Revista: Biomed Pharmacother Año: 2023 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trasplante de Células Madre Mesenquimatosas / Células Madre Mesenquimatosas Idioma: En Revista: Biomed Pharmacother Año: 2023 Tipo del documento: Article